Artery Advantage Circulatory Support
Enzymatic Therapy's Artery Advantage Circulatory Support is a botanical and nutrient blend designed to support circulatory health, featuring 6 ingredients with 100% label transparency. It achieves an N+ Score of 72, meriting a 'C' grade, indicating a good formulation. Key ingredients like Vitamin B6 (20 mg), Folic Acid (800 mcg), and Vitamin B12 (400 mcg) are provided at clinically studied dosages, which research suggests may support cardiovascular function. However, the Vitamin K2 content is underdosed. This product may benefit individuals looking for supplemental support for circulatory health.
About This Product
Artery Advantage Circulatory Support by Enzymatic Therapy is a vitamins & minerals supplement containing 6 active ingredients. It has earned an N+ Score of 72/100 (Grade C).
This product features a fully transparent label with individual ingredient amounts disclosed, and key ingredients are present at clinically effective doses based on peer-reviewed research.
Notable clinical-dose ingredients include Vitamin B6, Vitamin B12, Folic Acid.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Key ingredients at clinically effective doses
- +Fully transparent label with individual ingredient amounts disclosed
- +3 ingredient(s) at clinical dose levels
Weaknesses
- −No major weaknesses identified
Ingredient Analysis (6 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Vitamin B6 | 20.000 mg | Optimal |
| Vitamin B12 | 400.000 mcg | Optimal |
| Folic Acid | 800.000 mcg | Optimal |
| Vitamin K2 | 45.000 mcg | Under |
| Pomegranate Fruit Extract | 50.000 mg | N/A |
| Garlinase 5000 Garlic Blend | 320.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.